HeartBeam Reports Second Quarter 2023 Financial Results

Further Strengthens Board of Directors and IP Position, Publishes First Peer-Reviewed Article


Management to Host Webcast and Conference Call Today At 4:30 p.m. ET

...
-Today at 04:03 pm- MarketScreener

Related Keywords

Boston ,Massachusetts ,United States ,Heartbeam Aimigo ,Ken Nelson ,Robert Eno ,Mark Strome ,Michael Jaff ,Deborah Castillo ,Richard Brounstein ,Branislav Vajdic ,Journal Of American College Cardiology ,Clinical Affairs ,Regulatory Affairs ,Nasdaq ,Trademark Office ,Boston Scientific Corporation ,Heartbeam Inc ,Drug Administration ,Registered Direct Offering ,American College ,Vice President ,United States Patent ,Intellectual Property ,Chief Executive Officer ,Chief Medical Officer ,Peripheral Interventions ,Common Stock ,Founder Branislav Vajdic ,President Robert Eno ,Risk Factors ,Financial Condition ,Balance Sheets ,Stockholder Equity ,Cash Flows ,Cash Equivalents ,Cash Flow Information ,Non Cash Financing Activities ,Markets ,